Clinical trials referenced in this document:
Funding for this research was provided by:
Regional Artemisinin-resistance Initiative (RAI3E) grant (QSE-M-UNOPS-BI-20864-007-60)
National Health and Medical Research Council
Received: 20 July 2022
Accepted: 11 September 2022
First Online: 24 September 2022
: The study protocol (version 1.1 dated 29th June 2021) was approved by the National Ethics Committee for Health Research, Cambodia (252 NECHR) and Lao PDR (09/NECHR), and Alfred Hospital Ethics Review Committee, Australia (388/21). Any major modifications to the study protocol will be communicated to the ethics review committees as required.Written consent (Additional file InternalRef removed) will be obtained by researchers and trained data collectors from all study participants (MMPs and field staff) before data collection (baseline and end-line surveys, focused group discussions and interviews) and implementation of the trial. For enrolling the selected villages into the stepped-wedge trial, written informed consents will be taken from the malaria volunteer who is taking care of malaria services in the villages. Written informed consents for the RDT and dried blood spot samples collection will be obtained from the MMPs and other villagers who are seeking for malaria testing and treatment services at the malaria volunteers. It will be performed by the malaria volunteers just before taking the samples from them. If a participant withdraws from the study during implementation, data collection pertaining to that person will stop but the data participant already provided before withdrawal from the study will be included in the analysis.<b>Dissemination of study results</b>A final technical report will be produced, and a final dissemination workshop will be held with the implementing partners to disseminate the findings of the study. Findings may also be presented at international and national conferences and published in peer-reviewed journals.
: Not applicable.
: The authors declare that they have no competing interests.